ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
8 announcements with these filters
Promoter Chemikas Speciality LLP pledged 10,87,500 shares of Archean Chemical Industries as loan collateral on 17 Sept 2026. Total encumbered holding rose to 30.53% of the company.
Chemikas Speciality LLP created a pledge on 30,000 shares of Archean Chemical Industries Limited as collateral for loans.
SBI Mutual Fund sold 1,47,599 shares of Archean Chemical Industries Ltd, representing 0.1196% of the company's equity, via market sale on September 03, 2026.
Archean Chemical reported Q1 FY27 consolidated revenue of INR 3,328.1M, up 10.7% YoY. Standalone margins improved to 25.3%, with bromine derivatives business turning EBITDA positive for the first time.
Archean reported Q1FY27 consolidated revenue of ₹3,328 Mn, up 11% YoY. Strategy focuses on bromine derivatives, semiconductors via SiCSem, and energy storage through Offgrid Energy Labs.
Archean Chemical Industries Ltd reported revenue from operations of ₹327.2 Cr (+11.9% YoY) and net profit of ₹30.4 Cr (-24.2% YoY) for Q1 FY27.
Q4FY26 revenue at ₹306.3cr (consolidated). Management reports headwind from US-Iran conflict and Kutch logistics issues, but remains bullish on core salt and bromine expansion.
Archean Chemical Industries Ltd reported revenue from operations of ₹300.9 Cr (-12.9% YoY) and net profit of ₹12.2 Cr (-77.3% YoY) for Q4 FY26.